Amneal Pharmaceuticals, Inc. (AMRX)

Nasdaq · Healthcare · Drug Manufacturers - Specialty & Generic
$21.12-1.26%As of 2026-11-22 · USD
Last session low $21.07Last session high $21.70
52-week low $11.7152-week high $22.12
Market cap
$7.36B
Sector
Healthcare
P/E (TTM)
52.8x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)55.5In the neutral range (30 to 70)
MACD (12, 26, 9)0.41Below its signal line (0.41); histogram -0.01
Bollinger %B (20, 2)53%Inside the bands (19.77 to 22.33)
SMA 2021.05Price is 0.3% above
SMA 5020.14Price is 4.9% above
SMA 20016.28Price is 29.7% above
ATR (20)3.60% of priceAverage true range per day
52-week position90%In the upper part of the 11.71 to 22.12 range

About Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE.

Latest fiscal yearEnded 2025-12-31: revenue of $3.02B and an operating margin of 13.2%.

More in Drug Manufacturers - Specialty & Generic